To our knowledge, no comparative or cross-sectional studies have examined the expression of potential CSC markers alongside VDR in a cohort of patients with epithelial ovarian tumors (EOTs) exhibiting varying pathological features. This evidence concerns the gene VDR and ovarian epithelial tumor.